FdaApplication
NDA 022108
Identifiers
- fda_app_no: NDA022108
Properties
| Property | Value |
|---|---|
| applicant_name | BAUSCH HEALTH US LLC |
| application_type | NDA |
| approval_date | 2008-04-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APLENZIN | BUPROPION HYDROBROMIDE | 348MG | TABLET, EXTENDED RELEASE;ORAL |
| APLENZIN | BUPROPION HYDROBROMIDE | 174MG | TABLET, EXTENDED RELEASE;ORAL |
| APLENZIN | BUPROPION HYDROBROMIDE | 522MG | TABLET, EXTENDED RELEASE;ORAL |
3 products